GERON CORP Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
GERON CORP (GERN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $160.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2017-03-01
- GERON CORP other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2013-12-31 was -$2.00K.
- GERON CORP other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2013-09-30 was $1.00K, a 99.39% decline year-over-year.
- GERON CORP other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2013-06-30 was -$31.00K.
- GERON CORP other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2013-03-31 was -$22.00K, a 148.89% decline year-over-year.
- GERON CORP other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was $160.00K.
- GERON CORP other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2015 was -$129.00K.
- GERON CORP other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2014 was -$70.00K.
- GERON CORP other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2013 was -$54.00K, a 141.22% decline from fiscal 2012.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2016-12-31 | $160.00K 10-K · filed 2017-03-01 | |||
| 2015-12-31 | -$129.00K 10-K · filed 2017-03-01 | |||
| 2014-12-31 | -$70.00K 10-K · filed 2017-03-01 | |||
| 2013-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$1.00K derived: sum of 2 quarters · filed 2016-03-10 | -$32.00K derived: sum of 3 quarters · filed 2016-03-10 | -$54.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | $1.00K 10-Q · filed 2013-11-07 | -$30.00K derived: sum of 2 quarters · filed 2013-11-07 | -$52.00K 10-Q · filed 2013-11-07 | -$94.00K derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-06-30 | -$31.00K 10-Q · filed 2013-08-08 | -$53.00K 10-Q · filed 2013-08-08 | -$95.00K derived: sum of 3 quarters · filed 2015-03-11 | $68.00K derived: sum of 4 quarters · filed 2015-03-11 |
| 2013-03-31 | -$22.00K 10-Q · filed 2013-05-03 | -$64.00K derived: sum of 2 quarters · filed 2015-03-11 | $99.00K derived: sum of 3 quarters · filed 2015-03-11 | $64.00K derived: sum of 4 quarters · filed 2015-03-11 |
| 2012-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $121.00K derived: sum of 2 quarters · filed 2015-03-11 | $86.00K derived: sum of 3 quarters · filed 2015-03-11 | $131.00K 10-K · filed 2015-03-11 |
| 2012-09-30 | $163.00K 10-Q · filed 2013-11-07 | $128.00K derived: sum of 2 quarters · filed 2013-11-07 | $173.00K 10-Q · filed 2013-11-07 | $256.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$35.00K 10-Q · filed 2013-08-08 | $10.00K 10-Q · filed 2013-08-08 | $93.00K derived: sum of 3 quarters · filed 2014-03-17 | -$39.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $45.00K 10-Q · filed 2013-05-03 | $128.00K derived: sum of 2 quarters · filed 2014-03-17 | -$4.00K derived: sum of 3 quarters · filed 2014-03-17 | $93.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$49.00K derived: sum of 2 quarters · filed 2014-03-17 | $48.00K derived: sum of 3 quarters · filed 2014-03-17 | $5.00K 10-K · filed 2014-03-17 |
| 2011-09-30 | -$132.00K 10-Q · filed 2012-11-02 | -$35.00K derived: sum of 2 quarters · filed 2012-11-02 | -$78.00K 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $97.00K 10-Q · filed 2012-08-03 | $54.00K 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | -$43.00K 10-Q · filed 2012-05-07 | |||
| 2010-12-31 | $310.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |